Greg Zante Insider Profile
11 Followers
Greg Zante, CFO at Viking Therapeutics, holds 212.20K shares in Viking Therapeutics (Ticker: VKTX), holds 693.00 shares in Sangamo Therapeutics (Ticker: SGMOQ).
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-15.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Greg Zante holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 31, 2024 - Jul 31, 2025
Return:+42.80%
The most profitable trade made by Greg Zante
Greg Zante's Trading History
Viking Therapeutics
Jul 29, 2026
CFO
Uninformative Buy
―
$7.15M
Sangamo Therapeutics
―
VP, Finance & Administration
―
$110.88
List of latest transactions for each holding click on a transaction to see Greg Zante's performance on stock
You May Also Like
Greg Zante insider profile FAQ
What is the percentage of profitable transactions made by Greg Zante?
The percentage of profitable transactions made by Greg Zante is 43%.
What is the average return per transaction made by Greg Zante?
The average return per transaction made by Greg Zante is -15.60%.
What stocks does Greg Zante hold?
Greg Zante holds: VKTX, SGMOQ stocks.
What was Greg Zante’s latest transaction?
Greg Zante latest transaction was an Uninformative Buy of ―.
What was Greg Zante's most profitable transaction?
Greg Zante’s most profitable transaction was an Informative Sell of VKTX stock on July 31, 2024. The return on the trade was 42.80%.
What is Greg Zante's role in Viking Therapeutics?
Greg Zante's role in Viking Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.